BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 10, 2026
Home
»
Topics
»
Infection
» HIV/AIDS
HIV/AIDS
RSS
AlphaVax reports phase I findings for HIV vaccine
Sep. 8, 2006
Virax files to begin phase I/IIa study of VIR-201 HIV vaccine in S. Africa
Sep. 6, 2006
Improvements in metabolic risk factors in HIV lipodystrophy study of EG-005
Sep. 6, 2006
Samaritan and Georgetown University jointly disclose novel agents for HIV infection
Sep. 5, 2006
Phase I study of prime-boost vaccine shows T-cell immunity against HIV
Sep. 5, 2006
Pharmexa cleared to begin phase Ib study of HIV vaccine EP-1090
Aug. 31, 2006
Advances in anti-HIV microbicides reported at the recent AIDS conference
Aug. 30, 2006
Nigerian phase III study of Savvy ended early
Aug. 30, 2006
Plasmacytoid DCs regarded as targets for microbicides
Aug. 30, 2006
SPA for second pivotal study of TH-9507 in HIV-associated lipodystrophy
Aug. 29, 2006
Previous
1
2
…
168
169
170
171
172
173
174
175
176
…
423
424
Next
RSS